News | January 15, 2015

Society of Interventional Radiology Launches New Brand Reinforcing Commitment to Develop New Treatments

New branding designed to enhance medical practice and improve standard of patient care through image-guided therapies

January 15, 2015 — The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the SIR Foundation. The new logos for both organizations convey the limitless possibilities of image-guided therapies to solve the toughest medical problems. SIR’s new tagline, “The vision to heal,” reflects the innovative, patient-driven care that board-certified interventional radiologists deliver through methods that result in less risk, less pain and shorter recovery time than traditional surgery.

“Interventional radiology showcases the very best of today’s medicine, bringing together clinical insight, procedural expertise and advanced image-guided technology to deliver high-quality patient care,” said SIR President James B. Spies, M.D., MPH, FSIR. “Our efforts reinforce how SIR continues to support our members as they deliver outstanding clinical care and how we will continue to do so in the years to come,” added Spies.

With the renewed focus on cost-effective, patient-driven care in the evolving healthcare landscape, SIR and SIR Foundation actively reaffirm interventional radiology’s role as part of the greater care team. Through the new brand, the society strengthens its identity, promoting the value that interventional radiology delivers — the same value being called for in medicine: better outcomes, less burden on the patient and innovative use of technology with clear patient benefit, noted Spies.

“Our new brand helps us to better communicate the valuable and unique role that interventional radiology has in delivering comprehensive clinical care,” said SIR Executive Director Susan E. Sedory Holzer, M.A., CAE. “By listening to our members, this new framework also reflects the passion and dedication members have for the specialty and, more importantly, high-quality care,” added Holzer.

For more information: www.sirweb.org

Related Content

Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
FDA Clears NvisionVLE Imaging System for Pancreatic and Biliary Applications

Image courtesy of NinePoint Medical

Technology | Interventional Radiology | August 14, 2019
August 14, 2019 — NinePoint Medical Inc. announced it has received U.S.
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
WVU Medicine Installs First Alphenix 4D CT in the U.S.
News | CT Angiography (CTA) | July 24, 2019
The West Virginia University (WVU) Heart and Vascular Institute is the first hospital in the country to acquire the...
Varian Purchasing Embolic Bead Assets from Boston Scientific
News | Interventional Radiology | July 03, 2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Interventional Radiology | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
Merit Medical Acquires Brightwater Medical Inc.
News | Interventional Radiology | June 19, 2019
Merit Medical Systems Inc. announced it has acquired Brightwater Medical Inc., based in Temecula, Calif. Brightwater...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res